{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:08:07Z","timestamp":1791295687243,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T00:00:00Z","timestamp":1439510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0135463","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T14:10:45Z","timestamp":1439561445000},"page":"e0135463","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Microarray and Proteomic Analyses of Myeloproliferative Neoplasms with a Highlight on the mTOR Signaling Pathway"],"prefix":"10.1371","volume":"10","author":[{"given":"Vladan P.","family":"\u010coki\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Mossuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Socoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojana B.","family":"Beleslin-\u010coki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Mitrovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijana","family":"Suboti\u010dki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"Dikli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Lekovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Goti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj K.","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance Tom","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan N.","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1182\/blood-2014-03-530865","article-title":"From Janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasms","volume":"123","author":"M Cazzola","year":"2014","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32","author":"W Vainchenker","year":"2013","journal-title":"Oncogene"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2141.2009.07870.x","article-title":"Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms","volume":"147","author":"LF Grimwade","year":"2009","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/156800908783497140","article-title":"Deregulation of the Akt pathway in human cancer","volume":"8","author":"E Tokunaga","year":"2008","journal-title":"Curr Cancer Drug Targets"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2011-12-389932","article-title":"Aberrant STAT5 and PI3K\/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia","volume":"120","author":"SK Tasian","year":"2012","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ccr.2012.10.023","article-title":"JAK2\/STAT5 inhibition circumvents resistance to PI3K\/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer","volume":"22","author":"A Britschgi","year":"2012","journal-title":"Cancer Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1158\/1535-7163.MCT-12-0862","article-title":"Dual PI3K\/AKT\/mTOR inhibitor BEZ235 synergistically enhances the activity of JAK2 inhibitor against cultured and primary human myeloproliferative neoplasm cells","volume":"12","author":"W Fiskus","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e54826","DOI":"10.1371\/journal.pone.0054826","article-title":"mTOR inhibitors alone and in combination with JAK2 inhibitors effectively inhibit cells of myeloproliferative neoplasms","volume":"8","author":"C Bogani","year":"2013","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.exphem.2012.05.011","article-title":"Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis","volume":"40","author":"V Skov","year":"2012","journal-title":"Exp Hematol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e85567","DOI":"10.1371\/journal.pone.0085567","article-title":"Transcriptional profiling of whole blood identifies a unique 5-gene signature for myelofibrosis and imminent myelofibrosis transformation","volume":"9","author":"HC Hasselbalch","year":"2014","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1634\/stemcells.2006-0351","article-title":"Molecular profiling of CD34<sup>+<\/sup> cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms&apos; tumor gene 1 (WT1)","volume":"25","author":"P Guglielmelli","year":"2007","journal-title":"Stem Cells"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1634\/stemcells.2004-0131","article-title":"Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays","volume":"23","author":"LC Jones","year":"2005","journal-title":"Stem Cells"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1196\/annals.1349.013","article-title":"Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia vera","volume":"1044","author":"U Steidl","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.2005.05416.x","article-title":"Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2","volume":"129","author":"PS Goerttler","year":"2005","journal-title":"Br J Haematol"},{"key":"ref15","first-page":"3940","article-title":"Gene expression profiling in polycythemia vera using cDNA microarray technology","volume":"63","author":"A Pellagatti","year":"2003","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/leu.2008.112","article-title":"Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia","volume":"22","author":"E Puigdecanet","year":"2008","journal-title":"Leukemia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.exphem.2007.07.004","article-title":"JAK2V617F-negative ET patients do not display constitutively active JAK\/STAT signaling","volume":"35","author":"S Schwemmers","year":"2007","journal-title":"Exp Hematol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1182\/blood-2005-05-1889","article-title":"Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2","volume":"106","author":"R Kralovics","year":"2005","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1182\/blood-2003-07-2597","article-title":"Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells","volume":"104","author":"E Tenedini","year":"2004","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.exphem.2008.07.013","article-title":"Proteomic study of the impact of the JAK2-V617F mutation on the phenotype of essential thrombocythemia","volume":"36","author":"P Mossuz","year":"2008","journal-title":"Exp Hematol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1476-4598-12-142","article-title":"Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia Vera","volume":"12","author":"M Gallardo","year":"2013","journal-title":"Mol Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1479-5876-10-116","article-title":"JAK-STAT and AKT pathway-coupled genes in erythroid progenitor cells through ontogeny","volume":"10","author":"VP Cokic","year":"2012","journal-title":"J Transl Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK signal pathways in the regulation of cell proliferation in mammalian cells","volume":"12","author":"W1 Zhang","year":"2002","journal-title":"Cell Res"},{"key":"ref24","first-page":"1033","article-title":"Gemcitabine resistance in breast cancer cells regulated by PI3K\/AKT-mediated cellular proliferation exerts negative feedback via the MEK\/MAPK and mTOR pathways","volume":"7","author":"XL Yang","year":"2014","journal-title":"Onco Targets Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"JA Engelman","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-8722-7-17","article-title":"Pten regulates homeostasis and inflammation-induced migration of myelocytes in zebrafish","volume":"7","author":"ZW Dong","year":"2014","journal-title":"J Hematol Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2008.26","article-title":"Contributions of the Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways to leukemia","volume":"22","author":"LS Steelman","year":"2008","journal-title":"Leukemia"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.exphem.2006.05.002","article-title":"Constitutive phosphorylation of the S6 ribosomal protein via mTOR and ERK signaling in the peripheral blasts of acute leukemia patients","volume":"34","author":"S Chow","year":"2006","journal-title":"Exp Hematol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/1055-9965.EPI-13-0761","article-title":"Gene expression profiling in true interval breast cancer reveals overactivation of the mTOR signaling pathway","volume":"23","author":"F Rojo","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1158\/0008-5472.CAN-13-2278","article-title":"Cancer cells exploit eIF4E2-directed synthesis of hypoxia response proteins to drive tumor progression","volume":"74","author":"J Uniacke","year":"2014","journal-title":"Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.molcel.2013.12.004","article-title":"Ral and Rheb GTPase activating proteins integrate mTOR and GTPase signaling in aging, autophagy, and tumor cell invasion","volume":"53","author":"TD Martin","year":"2014","journal-title":"Mol Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"K Inoki","year":"2003","journal-title":"Genes Dev"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"J1 Huang","year":"2008","journal-title":"Biochem J"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.exphem.2004.10.017","article-title":"Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt\/PKB","volume":"33","author":"C Dai","year":"2005","journal-title":"Exp Hematol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1 05","DOI":"10.1634\/stemcells.2005-0062","article-title":"Mammalian target of rapamycin is required for thrombopoietin-induced proliferation of megakaryocyte progenitors","volume":"24","author":"AL Drayer","year":"2006","journal-title":"Stem Cells"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1182\/blood-2005-07-3005","article-title":"Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation","volume":"107","author":"H Raslova","year":"2006","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2141.2012.09246.x","article-title":"Increased phospho-mTOR expression in megakaryocytic cells derived from CD34<sup>+<\/sup> progenitors of essential thrombocythaemia and myelofibrosis patients","volume":"159","author":"L Vicari","year":"2012","journal-title":"Br J Haematol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/jcmm.12162","article-title":"Co-targeting the PI3K\/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms","volume":"17","author":"N Bartalucci","year":"2013","journal-title":"J Cell Mol Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e84746","DOI":"10.1371\/journal.pone.0084746","article-title":"Proliferation and survival signaling from both Jak2-V617F and Lyn involving GSK3 and mTOR\/p70S6K\/4EBP1 in PVTL-1 cell line newly established from acute myeloid leukemia transformed from polycythemia vera","volume":"9","author":"T Nagao","year":"2014","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood-2011-01-330563","article-title":"Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1\/2 study in patients with myelofibrosis","volume":"118","author":"P Guglielmelli","year":"2011","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3324\/haematol.13766","article-title":"Mammalian target of rapamycin activity is required for expansion of CD34<sup>+<\/sup> hematopoietic progenitor cells","volume":"94","author":"CR Geest","year":"2009","journal-title":"Haematologica"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0135463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T22:51:46Z","timestamp":1540335106000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0135463"}},"subtitle":[],"editor":[{"given":"Zoran","family":"Ivanovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,14]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0135463","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,14]]}}}